Phibro Animal Health | PAHC - 贷款资金

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	贷款资金	更改		日
Align Technology	USD 0		0	2024-12
ANI Pharmaceuticals	USD 291.84M		5.84M	2025-12
Assertio Holdings	USD 39.17M		120K	2025-09
Aurora Cannabis	CAD 33.2M		1.79M	2025-12
Bristol-Myers Squibb	USD 42.85B		1.62B	2025-12
Canopy Growth	CAD 224.99M		1.34M	2025-12
Eli Lilly	USD 40.87B		5.6M	2025-12
Henry Schein	USD 2.31B		157M	2025-12
Idexx Laboratories	USD 374.84M		17K	2025-12
Knight Therapeutics	CAD 57.78M		26.92M	2025-12
Merck	USD 39.97B		6B	2025-09
Nektar Therapeutics	USD 107.51M		10.35M	2024-06
Pacira	USD 372.19M		4.53M	2025-12
Phibro Animal Health	USD 603.6M		5.92M	2025-12
Prestige Brands	USD 1.05B		39.73M	2025-12
Supernus Pharmaceuticals	USD 400.38M		21.13M	2022-03
Zoetis	USD 9.04B		1.97B	2025-12